ZTS Q3 2022 Earnings — Zoetis Inc. Revenue & Financial Results | Market Cap Arena

ZTSZoetis Inc.

$54B

Q3 2022 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$2.0B+0.6% YoY

Gross Profit

$1.4B67.8% margin

Operating Income

$723M36.1% margin

Net Income

$529M26.4% margin

EPS (Diluted)

$1.13

QoQ Revenue Growth

-2.4%

Cash Flow

Operating Cash Flow

$526M

Free Cash Flow

$372M

Stock-Based Comp.

$15M

Balance Sheet

Total Assets

$13.7B

Total Liabilities

$9.0B

Stockholders' Equity

$4.7B

Cash & Equivalents

$2.5B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2.0B	$2.0B	+0.6%
Gross Profit	$1.4B	$1.4B	-0.4%
Operating Income	$723M	$728M	-0.7%
Net Income	$529M	$552M	-4.2%

Revenue Segments

Dogs and Cats

$1.2B62%

Cattle

$371M19%

Swine

$129M7%

Poultry

$116M6%

Fish

$60M3%

Horses

$58M3%

Geographic Segments

United States Segment

$1.1B55%

International Segment

$889M45%